Rockwell Medical, Inc.
NASDAQ:RMTI
Overview | Financials
Company Name | Rockwell Medical, Inc. |
Symbol | RMTI |
Currency | USD |
Price | 3.475 |
Market Cap | 107,829,945 |
Dividend Yield | 0% |
52-week-range | 1.16 - 4.57 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mark Strobeck Ph.D. |
Website | https://www.rockwellmed.com |
An error occurred while fetching data.
About Rockwell Medical, Inc.
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD